Twitter | Pretraživanje | |
Pretraživanje Osvježi
Atriva Therapeutics 13. sij
Learn more about ’s host-targeting therapy candidate against , hanta and further severe respiratory viral infections at the company presentation of our CEO, Dr. Lichtenberger, today at . Join us at 11:30, Franciscan D.
Reply Retweet Označi sa "sviđa mi se"
AllTime EDM 29. lip
THIS ONES FOR ALL YOU DUBSTEP LOVERS 😤
Reply Retweet Označi sa "sviđa mi se"
AllTime EDM 27. lip
Reply Retweet Označi sa "sviđa mi se"
Atriva Therapeutics 20. lis
Atriva Theraputics is now also on Twitter! We can’t wait to tell you more about our lead product , a clinical- stage, first-in-class host-targeting agent that inhibits viral replication in and other respiratory infections. Stay tuned!
Reply Retweet Označi sa "sviđa mi se"
Atriva Therapeutics 14. sij
We look forward to telling you more about , our host-targeting approach to treat , at the RESI conference, where 500+ early stage investors gather every year. Dr. Rainer Lichtenberger will present Atriva during the track 4, 8:00 am.
Reply Retweet Označi sa "sviđa mi se"
Atriva Therapeutics 4. stu
On Nov 11 , EU's largest life science partnering conference, starts in . Our CEO Dr. Lichtenberger is happy to discuss our lead product against , and other severe respiratory infections. Use to set up a meeting!
Reply Retweet Označi sa "sviđa mi se"
Atriva Therapeutics 1. stu
Let’s go by spreading awareness - today is ! Atriva commits to with our first-in-class host-targeting MEK inhibitor . We address the need for a novel, broadly active, resistance-avoiding therapy and for a prolonged treatment window.
Reply Retweet Označi sa "sviđa mi se"
Atriva Therapeutics 30. sij
Odgovor korisniku/ci @UK_Muenster
Prof. Ludwig ist ein großartiger Wissenschaftler und Kollaborator. Seit Jahren arbeiten wir erfolgreich mit ihm zusammen, um gegen zu entwickeln
Reply Retweet Označi sa "sviđa mi se"
Atriva Therapeutics 29. sij
The world is under virus attack, but German scientists are already on the move. spoke with Prof. Dr. Ludwig, developer of ’ host-targeting candidate, , about pandemic threats like , SARS, MERS and .
Reply Retweet Označi sa "sviđa mi se"